116 related articles for article (PubMed ID: 1832545)
1. Shedding of the soluble form of the CD8 complex by CD8+/HLA-DR+ cells in HIV-1-infected patients.
Agostini C; Pizzolo G; Zambello R; Trentin L; Siviero F; Vinante F; Morosato L; Francavilla E; Cadrobbi P; Semenzato G
AIDS; 1991 Jul; 5(7):813-9. PubMed ID: 1832545
[TBL] [Abstract][Full Text] [Related]
2. Serum soluble CD8 molecule is a marker of CD8 T-cell activation in HIV-1 disease.
Nishanian P; Hofmann B; Wang Y; Jackson AL; Detels R; Fahey JL
AIDS; 1991 Jul; 5(7):805-12. PubMed ID: 1909873
[TBL] [Abstract][Full Text] [Related]
3. Activation and differentiation antigens on T cells of healthy, at-risk, and HIV-infected children.
Plaeger-Marshall S; Hultin P; Bertolli J; O'Rourke S; Kobayashi R; Kobayashi AL; Giorgi JV; Bryson Y; Stiehm ER
J Acquir Immune Defic Syndr (1988); 1993 Sep; 6(9):984-93. PubMed ID: 7688045
[TBL] [Abstract][Full Text] [Related]
4. Increases in soluble CD8 antigen in plasma, and CD8+ and CD8+CD38+ cells in human immunodeficiency virus type-1 infection.
Yagi MJ; Chu FN; Jiang JD; Wallace J; Mason P; Liu Y; Carafa J; Bekesi JG
Clin Immunol Immunopathol; 1992 May; 63(2):126-34. PubMed ID: 1611715
[TBL] [Abstract][Full Text] [Related]
5. A distinctive form of soluble CD8 is secreted by stimulated CD8+ cells in HIV-1-infected and high-risk individuals.
Schlesinger M; Chu FN; Badamchian M; Jiang JD; Roboz JP; Goldstein AL; Bekesi JG
Clin Immunol Immunopathol; 1994 Nov; 73(2):252-60. PubMed ID: 7923932
[TBL] [Abstract][Full Text] [Related]
6. Increased levels of soluble CD8 and CD4 in patients with infectious mononucleosis.
Yoneyama A; Nakahara K; Higashihara M; Kurokawa K
Br J Haematol; 1995 Jan; 89(1):47-54. PubMed ID: 7833276
[TBL] [Abstract][Full Text] [Related]
7. Expression of activation antigens, HLA-DR and CD38, on CD8 lymphocytes during HIV-1 infection.
Kestens L; Vanham G; Gigase P; Young G; Hannet I; Vanlangendonck F; Hulstaert F; Bach BA
AIDS; 1992 Aug; 6(8):793-7. PubMed ID: 1418775
[TBL] [Abstract][Full Text] [Related]
8. Soluble CD8 levels in the CSF and serum of patients with multiple sclerosis.
Maimone D; Reder AT
Neurology; 1991 Jun; 41(6):851-4. PubMed ID: 1904563
[TBL] [Abstract][Full Text] [Related]
9. Correlation of CD8 lymphocyte activation with cellular viremia and plasma HIV RNA levels in asymptomatic patients infected by human immunodeficiency virus type 1.
Bouscarat F; Levacher-Clergeot M; Dazza MC; Strauss KW; Girard PM; Ruggeri C; Sinet M
AIDS Res Hum Retroviruses; 1996 Jan; 12(1):17-24. PubMed ID: 8825614
[TBL] [Abstract][Full Text] [Related]
10. Increased soluble CD8 (sCD8) in human immunodeficiency virus 1-infected children in the first month and year of life.
Gesner M; Di John D; Krasinski K; Borkowsky W
Pediatr Infect Dis J; 1994 Oct; 13(10):896-8. PubMed ID: 7854890
[TBL] [Abstract][Full Text] [Related]
11. Selective increase of activation antigens HLA-DR and CD38 on CD4+ CD45RO+ T lymphocytes during HIV-1 infection.
Kestens L; Vanham G; Vereecken C; Vandenbruaene M; Vercauteren G; Colebunders RL; Gigase PL
Clin Exp Immunol; 1994 Mar; 95(3):436-41. PubMed ID: 7907956
[TBL] [Abstract][Full Text] [Related]
12. Soluble interleukin 2 receptor and soluble CD8 levels in previously treated human immunodeficiency virus-negative hemophiliacs multiply transfused with a monoclonal antibody-purified factor VIII concentrate.
Smid WM; Martens A; van der Meer J; Hegge-Paping CS; Halie MR
Transfusion; 1997 Jan; 37(1):86-9. PubMed ID: 9024495
[TBL] [Abstract][Full Text] [Related]
13. Cyclosporine A and prednisolone inhibit lectin- and alloantigen-induced release of sCD8: correlation with proliferative responses.
Kim HS; Degiannis D; Raskova J; Raska K
Clin Immunol Immunopathol; 1991 Jul; 60(1):27-39. PubMed ID: 1904329
[TBL] [Abstract][Full Text] [Related]
14. Circulating HIV-specific CD8+ cytotoxic T cells express CD38 and HLA-DR antigens.
Ho HN; Hultin LE; Mitsuyasu RT; Matud JL; Hausner MA; Bockstoce D; Chou CC; O'Rourke S; Taylor JM; Giorgi JV
J Immunol; 1993 Apr; 150(7):3070-9. PubMed ID: 8454874
[TBL] [Abstract][Full Text] [Related]
15. Soluble interleukin-2 receptor and soluble CD8 in serum and cerebrospinal fluid during human immunodeficiency virus-associated neurologic disease.
Griffin DE; McArthur JC; Cornblath DR
J Neuroimmunol; 1990 Jul; 28(2):97-109. PubMed ID: 2113934
[TBL] [Abstract][Full Text] [Related]
16. Elevated levels of soluble CD8 molecule in patients with lymphatic filariasis.
Lal RB; Ramzy RM; Gad AA
Immunol Lett; 1990 Oct; 26(1):85-8. PubMed ID: 2148926
[TBL] [Abstract][Full Text] [Related]
17. Infection of CD8+ T lymphocytes with HIV. Requirement for interaction with infected CD4+ cells and induction of infectious virus from chronically infected CD8+ cells.
De Maria A; Pantaleo G; Schnittman SM; Greenhouse JJ; Baseler M; Orenstein JM; Fauci AS
J Immunol; 1991 Apr; 146(7):2220-6. PubMed ID: 1706390
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic analysis of CD8+ T lymphocytes in a cohort of HIV type 1-infected patients treated with saquinavir, ritonavir, and two nucleoside analogs for 1 year, and association with plasma HIV type 1 RNA.
Kaufmann GR; Zaunders JJ; Cunningham P; Cooper DA
AIDS Res Hum Retroviruses; 1999 Jul; 15(11):963-72. PubMed ID: 10445808
[TBL] [Abstract][Full Text] [Related]
19. Elevated in vivo and in vitro secretion of CD8-alpha molecules in patients with systemic lupus erythematosus.
Linker-Israeli M; Hyun S; Ozeri-Chen T; Wallace DJ; Banks K; Klinenberg JR
J Immunol; 1994 Mar; 152(6):3158-67. PubMed ID: 8144910
[TBL] [Abstract][Full Text] [Related]
20. Expression of CD69 on T-cell subsets in HIV-1 disease.
Pitsios C; Dimitrakopoulou A; Tsalimalma K; Kordossis T; Choremi-Papadopoulou H
Scand J Clin Lab Invest; 2008; 68(3):233-41. PubMed ID: 17917998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
